Philippe Armand - Department of Medical Oncology, Dana-Farber Cancer Institute

基本信息

浏览量：60

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 24 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND β-GLUCAN PGG IN RELAPSED/REFRACTORY INDOLENT B-CELL NON-HODGKIN LYMPHOMA

C.A. Jacobson,R. Redd,C. Reynolds, M. Fields,P. Armand,D.C. Fisher,E.D. Jacobsen, A.S. LaCasce,N. Bose, N. Ottoson, A. Freedman

Hematological Oncology（2019）

引用2浏览0引用

TREATMENT PATTERNS, CLINICAL OUTCOMES, AND BIOMARKER EVALUATION IN CLASSICAL HODGKIN LYMPHOMA: A PROSPECTIVE OBSERVATIONAL STUDY IN US ONCOLOGY PRACTICES

J. Svoboda,P. Armand,P. Porcu, J.M. Burke,D. Stevens, M. Moezi, M. Bajaj, E.H. Cull, Y. Wan,C. Duan, A. Forslund,S. Gajavelli,

Hematological Oncology（2019）

引用0浏览0引用

INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE

S.M. Ansell, N.L. Bartlett, R.W. Chen,A. Herrera, E. Domingo-Domenech,A. Mehta, A. Forero-Torres, R. Garcia-Sanz,P. Armand, S. Devata, A. Rodriguez Izquierdo, I.S. Lossos,

Hematological Oncology（2019）

引用7浏览0引用

PCN130 REAL-WORLD DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL)

F. Laliberté,X. Yang,G. Germain,M. Raut,M.S. Duh,S. Sen, D. Lejeune,C. Yee,K. Desai,P. Armand

VALUE IN HEALTH（2019）

引用0浏览0引用

NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 205 COHORT D 2-YEAR FOLLOW-UP

S. Ansell,R. Ramchandren, E. Domingo-Domènech,A. Rueda,M. Trněný,T. Feldman,H. Lee,M. Provencio, C. Sillaber,J. Cohen,K. Savage,W. Willenbacher,

Hematological Oncology（2019）

引用5浏览0引用

Real-World Treatment Patterns Among Patients (Pts) Diagnosed With Primary Mediastinal Large B-Cell Lymphoma (Pmbcl) In The United States (Us)

Xiaoqin Yang,François Laliberté,Guillaume Germain,Monika Kumar Raut,Mei Sheng Duh,Shuvayu Sen,Dominique Lejeune,Kaushal Desai,Phillippe Armand

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用23浏览0引用

Real-World Demographic And Clinical Characteristics Of Patients Diagnosed With Diffuse Large B-Cell Lymphoma (Dlbcl) In The United States (Us)

Xiaoqin Yang,François Laliberté,Guillaume Germain,Monika Kumar Raut,Mei Sheng Duh,Shuvayu Sen,Dominique Lejeune,Cristi Cavanaugh,Kaushal Desai,Phillippe Armand

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用0浏览0引用

Safety And Efficacy Of Autologous Stem Cell Transplantation In Lymphoma Patients In Their 70s

Lova Sun,Shuli Li,Phillippe Armand, Yi-Bin Chen,Zachariah DeFilipp

JOURNAL OF CLINICAL ONCOLOGY（2017）

引用2浏览0引用

A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC-EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)

P.F. Caimi,J.P. Eder,E.D. Jacobsen,C.A. Jacobson, A.S. LaCasce, M.A. Shipp,B. Chapuy, E. Labriola-Tomphins, F. Boisserie, S. Passe, E. Chesné, W. Pierceall,

Hematological Oncology（2017）

引用3浏览0引用

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013

Vincent Ribrag,Phillippe Armand,John Kuruvilla,Jean-Marie Michot,Craig H Moskowitz,Patricia Marinello,Ellen Snyder,Arun Balakumaran,Margaret A Shipp,Pier Luigi Zinzani

Journal for ImmunoTherapy of Cancer（2015）

引用3浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn